Grifols SA A (EUR)
GRF
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 23.66 | 24.01 |
| 52-Wk Range | - | - |
| Last Close | 23.86 |
| Mkt Cap (m) | 14,198.66 |
| Dividend yield | 1.52 |
| ISIN | ES0171996087 |
| Volume | 1,718,095.00 |
| Exchange Venue | XMAD |
Company Profile
Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.
Key Information
| Price/Earning | 23.86 |
| Price/Book | 3.05 |
| Price/Sales | 3.04 |
| P/CF | 15.14 |
| Rev Growth (3 year avg) | 7.98 |
| EPS Growth (3 year avg) | 0.04 |
| Operating Margin % | 22.01 |
| Net Margin % | 12.26 |
| Return on Equity | 13.82 |
| Debt/Equity | 1.47 |
Documents
Prospectus
| en 23/04/2015 |
Annual Report
| en 31/12/2019 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 3,355.38 | 3,934.56 | 4,049.83 | 4,318.07 | 4,486.72 | 5,098.69 |
| Operating Income (m) | 857.69 | 970.37 | 939.41 | 1,003.34 | 994.12 | 1,122.39 |
| Net Income (m) | 470.25 | 532.15 | 545.46 | 662.70 | 596.64 | 625.15 |
| Basic EPS | 0.69 | 0.78 | 0.80 | 0.97 | 0.87 | 0.91 |
| Avg. Diluted Shares Outstanding (m) | 685.34 | 685.66 | 684.17 | 684.24 | 684.71 | 685.12 |
Balance Sheet
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 2,913.12 | 3,089.47 | 3,122.51 | 2,945.32 | 3,483.25 | 5,362.18 |
| Non Current Assets (m) | 5,536.63 | 6,512.24 | 7,007.26 | 7,974.95 | 8,993.80 | 10,180.43 |
| Total Assets (m) | 8,449.75 | 9,601.72 | 10,129.77 | 10,920.26 | 12,477.05 | 15,542.61 |
| Current Liabilities (m) | 1,079.71 | 1,053.01 | 1,071.76 | 977.99 | 1,257.32 | 1,366.56 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 2,658.12 | 3,296.20 | 3,721.48 | 3,629.08 | 4,225.55 | 4,822.12 |
Cash Flows
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | 978.93 | 742.78 | 553.28 | 841.75 | 737.43 | 568.93 |
| Capital Expenditure (m) | -287.04 | -567.02 | -292.69 | -322.97 | -307.72 | -412.31 |
Figures are quoted in EUR unless stated otherwise
-0.20 (-0.84%)
€
23.66
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.